RE: Extruded Pharmaceuticals Limited13 May 2024 16:58
£5,503 turnover. Damn. Loses of £338,534? Those could double if the new man takes the same salary as Robin. Cash will all be gone in 18 months and they will do a placing. Better vote NO and get a return of capital. Put your return in GSK a proper pharmaceutical company. This company that produces this plastic instrument is not going to cut it. One product company. They should have just sold the IP. They want a listing in order to obtain more capital as they know they will need it. This is a poor RTO. VOTE NO